Connect with us

TechCrunch

FindAir is a smart inhaler

FindAir is digitizing asthma therapy with smart inhaler technology. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech…

Published

on

FindAir is digitizing asthma therapy with smart inhaler technology.

The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education.

TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Continue Reading
Advertisement
9 Comments

9 Comments

  1. Abhishek Rao Chimbili

    October 27, 2019 at 4:51 pm

    That is the most useless thing I’ve ever seen.

  2. Brandon S.

    October 27, 2019 at 4:52 pm

    You are supposed to use a spacer. The inhaler alone is not good. Not to mention there are some inhalers that already track the number of uses. This is pointless.

  3. Greg Nulik

    October 27, 2019 at 7:21 pm

    Hope the sensor supports a full dosage.

  4. polyannamoonbeam

    October 27, 2019 at 10:39 pm

    Not enough info …sensor tells you what your trigger was…? How? Blood prick analysis? Heartrate? Allergen analysis? Doctors are now instructed to ration patients to one Ventolin a month, two if you argue at length. There is no science to back up patients self diagnosed need for more, doctors differ on what is sufficient, how to measure severity and are often punitive/ biased against smokers. Many patients become resistant to their Ventolyn due to misuse, long term use.. tracking usage doesnt tell you whether patient needed to use more or less puffs for each event or just misused due to poor technique….severe attacks are not managed by Ventolin. Steroids,adrenalin, intravenous meds, full mask vaporised meds- we use all in winter for son.

  5. Pinitrius

    October 27, 2019 at 11:34 pm

    Being an allergist I was interested to see what this was about… But no! It gives some information about patient adherence to the treatment but as with many products/service it is trying to force a subscription down patients throat without providing real long term value! And the product itself is rendered useless after 12 months due to the non-removable battery!

    To me it is just a gimmick the way they chose to make it and charge for it! Sorry…

  6. TechPimp

    October 28, 2019 at 1:51 am

    I didn’t understand what the heck it does?

  7. Gezaei Teklay

    October 28, 2019 at 2:09 am

    I hope it is helpful for asthma

  8. Arthur

    October 28, 2019 at 9:12 am

    So it counts how many times you use an inhaler a day and displays it on an app?

  9. takeonparis

    October 29, 2019 at 12:15 am

    This is the dumbest interview I’ve ever seen. He doesn’t even bother to ask: “So what does your product DO?” Like what in the actual hell…

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

When it Comes to Pitching, Don’t be Nice, Just Slay │ Build Mode Podcast

For women entering the founding and startup ecosystem, Taskrabbit founder Leah Solivan has a wealth of insights, especially on why you shouldn’t hold yourself back. Listen in on the latest episode of Build Mode for our full interview with her:

Published

on

For women entering the founding and startup ecosystem, Taskrabbit founder Leah Solivan has a wealth of insights, especially on why you shouldn’t hold yourself back.

Listen in on the latest episode of Build Mode for our full interview with her:

Continue Reading

Science & Technology

A diverse team will make your startup more successful with Leah Solivan, Taskrabbit l Build Mode

If one thing has become clear this season, finding the right talent for your team isn’t as easy as picking from a pile of resumes This week’s guest is Leah Solivan, the founder of Taskrabbit and now an early-stage investor who has seen that the power to change a homogenous startup exosystem comes from empowering…

Published

on

If one thing has become clear this season, finding the right talent for your team isn’t as easy as picking from a pile of resumes This week’s guest is Leah Solivan, the founder of Taskrabbit and now an early-stage investor who has seen that the power to change a homogenous startup exosystem comes from empowering diverse VCs to fund underrepresented founders who will hire the hidden tech talent.

From bootstrapping TaskRabbit on credit cards to scaling it into one of the defining companies of the gig economy, Leah learned firsthand that the hardest part of building a company isn’t the product, it’s selecting the right people to build it.

In this episode, Isabelle Johannessen and Leah unpack what it really takes to build diverse teams from day one and why most companies get it wrong by waiting too long. They also explore how the lack of diversity in venture capital directly shapes who gets funded, and ultimately, who gets hired.

Apply to Startup Battlefield: We are looking for early-stage companies that have an MVP. So nominate a founder (or yourself): techcrunch.com/apply. Be sure to say you heard about Startup Battlefield from the Build Mode podcast.

TechCrunch Disrupt: If you’re thinking about applying to Startup Battlefield, then October 13 to 15 in San Francisco, we’re back for TechCrunch Disrupt, where the Startup Battlefield 200 takes the stage. So if you want to cheer them on, or just network with 1000s of founders, VCs, and tech enthusiasts, then grab your tickets.

Use code buildmode15 for 15% off any ticket type.

Chapters:
00:00 The hard way to hire diverse talent
01:20 From engineer to Taskrabbit founder
03:39 The moment that sparked Taskrabbit
07:39 Why building teams is the hardest part
12:06 Learning how to hire from scratch
17:36 Why venture capital lacks diversity
27:25 How to build diverse teams from day one
39:42 What founders get wrong about competition

New episodes of Build Mode drop every Thursday. Hosted by Isabelle Johannessen. Produced and edited by Maggie Nye. Audience development led by Morgan Little. Special thanks to the Foundry and Cheddar video teams.

Continue Reading

Science & Technology

The new competition for your cap table | Equity Podcast

The VC middleman is getting cut out faster than anyone expected. Family offices and private wealth firms are going direct: writing checks, taking board seats, even incubating companies from scratch. And more founders are starting to notice. In February alone, family offices made 41 direct investments, including one Midwest-based firm that led a $230 million…

Published

on

The VC middleman is getting cut out faster than anyone expected. Family offices and private wealth firms are going direct: writing checks, taking board seats, even incubating companies from scratch. And more founders are starting to notice. In February alone, family offices made 41 direct investments, including one Midwest-based firm that led a $230 million Series B into an AI chip startup.

On this episode of TechCrunch’s Equity podcast, Rebecca Bellan caught up with Mitch Stein and Ari Schottenstein, founder and head of alternatives at ARENA Private Wealth, to find out what this shift means for founders, cap tables, and the future of AI investment.

Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod.

Chapters:

00:00 Intro

03:13 Why family offices are going direct now

06:03 The gen 2 & gen 3 family office shift

07:22 Is this strategic or just AI FOMO?

10:17 How Arena got into the Positron deal

14:30 Why founders want private wealth on their cap table

18:31 Due diligence on technical companies

21:56 Red flags founders should watch for

25:04 Are VCs threatened by this trend?

27:47 Taking board seats & level of involvement

34:17 Outro

Continue Reading

Trending